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Abstract
Pelvic organ prolapse and urinary incontinence are
among the most common chronic disorders in women.
These are common problems whose pathogenesis
remains unclear. As life expectancy increases, significantly
greater number of women now present with pelvic organ
prolapse and urinary incontinence requiring surgical
intervention. Currently, the lifetime risk of undergoing
prolapse or continence surgery is one in 11, and up to
30% of patients will require repeat reconstructive surgery
and repeat surgery for incontinence in 10%. In an attempt
to improve surgical outcomes and to preserve vaginal
capacity and coital function, a number of synthetic and
biological prostheses have been developed. This review
aims to look at the role of graft and mesh in vaginal
surgery. We conducted a search for English-language
articles published during 1997 to 2016, using  MEDLINE,
PubMed and United States' National Library of Medicine
databases. We reviewed around 50 papers but referenced
only 30 for this article. The literature review provided us a
new insight regarding safety of mesh. Polypropylene
mesh is safe for vaginal surgery if used by experienced
surgeons. The safety of mesh becomes compromised in
the hands of commercial surgical kit providers. All the
new mesh tailored kits should undergo evidence-based
trials and then can be safely used worldwide.
Keywords: Mesh, Graft, Pelvic organ prolapse, Urinary
incontinence.
Introduction
Pelvic organ prolapse (POP) and urinary incontinence (UI)
affect nearly one quarter of women in the United States
(US) and it is estimated that stress urinary incontinence
(SUI) alone results in more than $12 billion in annual
expenditures.1 Although many non-surgical treatments
exist, 11% to 19% of women undergo surgery.2 However,
even after surgery, up to one-third of women have
recurrent symptoms and require an additional operative
procedure.3 Surgical mesh has been promoted for the
treatment of women with POP to improve long-term
outcomes similar to mesh use for hernia repair, but during
last decade pharmaceutical-driven use of mesh kits
brought some serious complication. In 2012, the US Food
and Drug Administration (FDA) issued the first safety
communication regarding serious complications
associated with the use of trans-vaginal mesh for
treatment of prolapse.4 In 2014, the FDA mandated
premarket studies to evaluate the safety and effectiveness
of vaginal mesh implants and, in January 2016,
reclassified them as class III high-risk devices.5
There is a paucity of evidence regarding the use of mesh
in POP repair6 and it has been recommended by American
Urogynaecologic Society's guidelines developing
committee7 that placement of vaginal mesh should only
be performed by experienced, knowledgeable surgeons
who track their outcomes and provide rigorous informed
consent. In this article we will review the use of mesh in
vaginal surgery along with its complications and latest
recommendations.
Terminology
A brief description of the terminology used for pelvic
organ prolapse and SUI is given below. This was given by
joint committee of International Continence Society (ICS)
and International Urogynaecological Association (IUGA)
2016.8
Urodynamic stress incontinence: involuntary leakage of
urine during filling cystometry, associated with increased
intra-abdominal pressure, in the absence of a detrusor
contraction. In the circumstances where this diagnosis is
only made when the POP is reduced, the additional term
"occult" is appropriate.
Pelvic organ refers most commonly to the uterus and/or
the different vaginal compartments and their
neighbouring organs such as bladder, rectum or bowel.
POP Symptoms
Prolapse symptoms include a departure from normal
sensation structure or function, experienced by the
woman in reference to the position of her pelvic organs.
Symptoms are generally worse in situations when gravity
might make the prolapse worse (e.g., after long periods of
standing or exercise) and better when gravity is not a
factor e.g., lying supine.
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Specific Defects Definitions
Anterior vaginal wall (compartment) prolapse is defined
as observation of descent of the anterior vaginal wall
(compartment). Most commonly this might represent
bladder prolapse (cystocele). Higher stage anterior
vaginal wall prolapse will generally involve descent of
uterus or vaginal vault (if uterus is absent). Occasionally,
there might be an anterior enterocele (hernia of
peritoneum and possibly abdominal contents), most
commonly after prior reconstructive surgery.8
Posterior vaginal wall (compartment) prolapse is defined
as observation of descent of the posterior vaginal wall.
Commonly, this would represent rectal protrusion into
the vagina (rectocele). Higher stage posterior vaginal wall
prolapse after prior hysterectomy will generally involve
some vaginal vault (cuff scar) descent and possible
enterocele formation. Enterocele formation can also
occur in the presence of an intact uterus.8
Vaginal vault (cuff scar) prolapse is the observation of
descent of the vaginal vault (cuff scar after hysterectomy).
Graft/Mesh Terminology
Due to increasing use of commercially available mesh kits,
new terminology was developed by the joint committee
of IUGA and ICS. The group defined various prostheses,
grafts, complications related to their use by a standard
terminology.9,10
Prosthesis: a fabricated substitute to assist a damaged
body part or to augment or stabilise a hypoplastic
structure.
Mesh: A (prosthetic) network fabric or structure; open
spaces or interstices between the strands of the net. The
use of this term would be for POP surgery with synthetic
materials.
Mesh kit: A set of articles or equipment utilised for POP
surgery containing mesh with a system of trocars
designed to achieve mesh fixation or allow mesh passage
to or through specific areas within the pelvis.
Implant: A surgically inserted or embedded prosthesis or
graft. (Explant: a surgically excised prosthesis or graft).
Tape (Sling): A flat strip of synthetic material. The use of
this term would be for incontinence surgery with
synthetic materials.
Graft: Any tissue or organ for transplantation. This term
will be used to refer to biological materials inserted.
Autologous grafts: From patient's own tissues, e.g.,
rectus sheath or fascia lata. 
Allografts: From postmortem tissue banks.
Xenografts: From other species, e.g. modified porcine
dermis, porcine small intestine and bovine pericardium.
Trocar: A surgical instrument with either a pyramidal,
conical or needle-type cutting or dissecting point.
Tissue: A collection of similar cells and the intercellular
substances surrounding them.
Native: Pertaining to birth — "in situ" autologous.
Prominence: Parts that protrude beyond the surface with
no epithelial separation.
Separation: Physically disconnected (e.g. vaginal
epithelium).
Exposure: A condition of displaying, revealing, exhibiting
or making accessible (e.g. a permanent suture visualised
through separated vaginal epithelium).
Extrusion: Passage gradually out of a body structure or
tissue (e.g. a permanent suture protruding into the
vaginal cavity.
Perforation: Abnormal opening into a hollow organ or
viscous.
Dehiscence: A bursting open, splitting or gaping along
natural or sutured lines.
Sinus tract formation: (localised) formation of a fistulous
tract towards vagina or skin, where there is no visible
suture material in the vaginal lumen or overlying skin.
Granulation: Fleshy connective tissue projections on the
surface of a wound, ulcer or inflamed tissue surface.
Ulcer: A lesion through the skin or a mucous membrane
resulting from loss of tissue, usually with inflammation.
Site-specific defects and use of mesh
Surgical outcome in anterior vaginal
wall defects
Cystocoele, whether isolated or associated with apical
and/ or posterior prolapse, is found in 80% of patients
with genital prolapsed.3 The apical involvement of the
prolapse is likely to be more common than observed, and
combining sufficient support for the apex of the vagina is
necessary to ensure durable surgical outcome. Using
mesh instead of native tissues may lead to more efficient
support of the pelvic floor. A randomised study on 389
women compared Prolift mesh kit with native tissue for
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repair of cystocele by anterior colporrhaphy.11 The study
results revealed that mesh improved anatomical
outcomes, but pain and sexual function were not
statistically different between groups.
Trocar-based mesh kits like Elevate and Perigee are used
to correct anterior and apical defects. The Elevate Ant
mesh is fixed using hooks in the sacrospinous ligament on
either side, unlike the Perigee mesh, which crosses
through the obturator muscle just over the ischial spine
(Figure).
A retrospective non-randomised study12 compared the
results of Elevate Ant™ single-incision mesh (Elevate
Anterior group) in 84 patients and Perigee™ transvaginal
mesh (Perigee group) in 42 patients. Follow-up at 1 and 2
years comprised objective Pelvic Organ Prolapse
Quantification System (POP-Q) and subjective (Pelvic
Floor Distress Inventory-20 [PFDI-20], Pelvic Floor Impact
Questionnaire-7 [PFIQ-7], Pelvic Incontinence Sexual
Questionnaire-12 [PISQ-12]) assessments. The primary
end-point was objective success which was significantly
better with the use of the Elevate Ant mesh with better
apical correction at 2 years.
When different trocar-based kits were compared, anterior
Prolift and Perigee did not show a difference for anatomic
or subjective outcomes, mesh erosion or dyspareunia
rates. The risk of repeat surgery for recurrent cases in 5
years showed that the use of mesh for anterior prolapse
was associated with an increased risk of any repeat
surgery, which was driven by surgery for mesh removal.
Native tissue and vaginal mesh surgery had similar 5-year
risks of surgery for recurrent prolapsed.13
In summary, the heterogeneous evidence comparing use
of various grafts and mesh with each other in repair of
anterior vaginal wall prolapse limits our ability to draw
conclusions. Like in other comparisons, synthetic non-
absorbable mesh tends to provide superior outcomes
compared with other surgical repairs.
Surgical Outcome in Posterior Vaginal Wall
Defects
The current evidence suggests there is no difference in
anatomic and quality-of-life outcomes when using
synthetic absorbable mesh, synthetic non-absorbable
mesh, or biologic graft compared with native tissue for
transvaginal repair of posterior vaginal prolapse.6 One
study by Paraiso et al. in 200614 showed significantly
higher anatomic failure rates after graft-augmented
repair compared with native tissue posterior
colporrhaphy, whereas the other found no difference
between groups. Both studies showed no difference for
symptomatic outcomes and no graft exposures.
Anatomic failure with posterior repair is poorly defined
and it occurs less often when polypropylene mesh was
used to augment a transperineal levatorplasty.
A prospective multicentre study15 included 139 women
with >stage2 posterior vaginal prolapse and/or apical
descent. These women were surgically treated using
Elevate Apical and Posterior single-incision mesh system
(SIMS) with IntePro Lite for POP repair. Surgical outcome
was assessed by clinical examination and cure was
defined as reduction in staging of prolapse. The primary
endpoint was the percentage of patients with posterior
and/or apical stage < I ("cure") at follow-up. Secondary
endpoints included rate of mesh extrusion and disease-
specific quality of life outcomes. One-year follow-up
results showed objective posterior wall and apical cure
rates to be 92.5 and 89.2%, respectively, with an extrusion
rate of 6.5%.
Surgical Outcome in Vault Prolapse
Post-hysterectomy vaginal vault prolapse (PHVP) has a
reported incidence of 0.36 to 3.6 per 1,000 woman years
or a cumulative incidence of 0.5%.16 It is usually treated by
abdominal Sacrocolpopexy or vaginal sacrospinous
fixation (SSF) which is a conventional surgery for both
prevention and treatment of vault prolapse. While Level I
evidence supports the use of polypropylene mesh in
terms of anatomical outcomes in abdominal
sacrocolpopexy, evidence is less robust in supporting
transvaginal mesh kits balancing anatomical successes.17
Recently there have been an increase in the use of mesh-
based surgery using Prolift and Apogee mesh kits. Prolift
aims at support of the weakened vaginal walls of the
anterior and posterior compartments and suspension of
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Figure: Shows the anatomical view of the two meshes Elevate and Perijee, used for
correction od anterior and apical defects.
the apical compartment by means of a bilateral
sacrospinous ligament fixation. By this method Delancy
level 1 support18 is restored. An observational cohort
study of 46 patients who had post-hysterectomy vault
repair with Prolift showed an anatomic success rate of
91% at 12 months.19 Prolift has also been compared with
SSF in a randomised controlled multicentre trial20 which
found that the prolapse recurrence rate was significantly
higher at 12 months in the SSF group (39.4%) than in the
mesh group (16.9%; p=0.003).
There is an overall high, short-term objective success rate
(ranging from 87 to 95%) of the commonly used mesh kits
in the treatment of apical vaginal prolapse. The mean
objective success rate for correction of vault prolapse was
highest in the Apogee group, and comparable results
were obtained by procedures with the use of
polypropylene mesh for apical support. These results are
in accordance with the reported long-term success rates
of vaginal sacrospinous fixation.21
Use of Mesh in Anti-Incontinence Surgery
About 41%22 of women with urinary incontinence report
SUI as their primary symptom. The first line of
management is behavioural modifications and pelvic
floor muscle training, and once it fails, surgical treatment
is the mainstay of treatment for SUI.
Midurethral synthetic slings (MUSS) have been
established as the surgical intervention of first choice. All
commercially available MUSS are made from uncoated,
knitted, macroporous, type 1 polypropylene mesh. One of
the first commercially available MUSS, known as the
tension-free vaginal tape (TVT), is a retropubic sling and
remains one of the most popular and widely studied
midurethral sling.23 Due to the recognised complications
of retropubic mid-urethral slings such as voiding
dysfunction and the potential for bowel, bladder, and
vascular injuries, different methods of anatomic
placement of the synthetic mesh were designed. In an
effort to develop safer and less invasive passage of the
trocar, or needle, through the retropubic region a
transobturator tape was introduced24 which passes
through the obturator and puborectalis muscles,
reproducing the natural suspension fascia of the urethra
while preserving the retropubic space. Subsequent
clinical trials have demonstrated that transobturator
slings are associated with equivalent subjective cure rates
to retropubic slings, with less associated voiding
dysfunction and fewer bladder perforations25 but with
lower objective cure rates and greater risk of post-
operative neurologic symptoms in the obturator region.
The popularity of MUSS has come under scrutiny with the
FDA's public health notification26 and warning against
some MUSS. While the FDA has not yet released its final
recommendations on these devices it is recommended
that selection of patients, procedure and type of mesh
should always be performed by an experienced surgeon.
De-Novo Prolapse Formation in the
Non-Affected Vaginal Compartment
A corrective procedure in one compartment might
predispose for prolapse in a different anatomic
compartment due to further progression of lack of pelvic
support.27 The surgical correction of vault prolapse by SSF
has been associated with anterior vaginal defects which
usually appear one year after surgery. A prospective study
of 111 women aimed at the incidence of de novo anterior
prolapse after correction of posterior compartment
prolapse by mesh kit Elevate® Posterior.  De novo anterior
prolapse emerged in 3.2-15% of the women,28 although it
was found effective in terms of both objective and
subjective outcomes.
Mesh Complications
Surgical treatment of POP and stress urinary incontinence
(SUI) involves the use of synthetic materials. Placement of
synthetic mesh into the vaginal wall, through either the
vagina includes the risk of multiple complications.29 The
incidence of mesh-related infections and erosion range
from 0 to 8%, and 0 to 33%, respectively, in published
studies.30
In contrast to mesh used for treating SUI, there is a
paucity of data regarding long-term outcomes and
complication rates of transvaginally placed mesh for
treatment of pelvic organ prolapse. Sutures used to
attach prolapse mesh to the vagina and the pelvic
sidewall or sacrum act as point loads. Applying point
loads during uniaxial loading results in out-of-plane
deformation which results in mesh wrinkling, buckling,
and/or folding.31 In addition to wrinkling with uniaxial
loading, prolapse meshes exhibit a marked decrease in
pore size and a loss in porosity. After exposing the
transvaginal meshes Prolift and Prolift plus M to relatively
small loads, Otto et al. detected a loss of porosity in both
the arms and central body of the mesh.32 In a further
assessment of prolapse meshes loaded in a
sacrocolpopexy model, Barone et al. saw similar results.33
The complications with the use of synthetic mesh occur
due to its placement adjacent to the bladder and rectum
involving extensive paravesical and pararectal dissection
includes the passage of needles blindly through the
obturator foramen or the ischiorectal fossa which in turn
increase the potential for immediate complications like
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excessive bleeding, perforation of the bladder, rectum
and blood vessels. Delayed complications include mesh
erosion, severe mesh infections, deep fascial necrosis,
fistulae and dyspareunia.
Mesh Complication with Commitant Vaginal
Surgery
Surgery for SUI using midurethral sling along with vaginal
hysterectomy and pelvic floor repair has shown no
additional morbidity.2 A prospective multicentre study34
was conducted to evaluate the anatomical and functional
results of a low-weight polypropylene mesh (Ugytex,
Sofradim, Trévoux, France, distributed by Bard as Pelvitex)
coated with an absorbable film. The Mesh was used for
anterior (A), posterior (P) and combined AP repair.
Concomitant procedures such as midurethral slings were
performed in 70 cases, vaginal hysterectomy in 52,
sacrospinous suspension in 13 and trachelectomy in 5
patients. During the one-year follow up, 9 vaginal
erosions of the mesh occurred (6.3%). Five out of nine
erosions occurred before 3 months, but the median
follow-up for the diagnosis of erosion was 80 days
(ranging from 38 to 380). Eight out of nine erosions
occurred anteriorly, on the distal part of the vertical
midline incision. Concomitant vaginal surgery increases
the risk of mesh complications as six erosions occurred on
the 57 patients with concomitant hysterectomy or
trachelectomy (10.5%) and three on the 86 patients with
uterine conservation or previous hysterectomy (3.5%)
(p=0.089).
Conclusion
The heterogeneous evidence comparing use of various
grafts and mesh with each other in repair of POP limits our
ability to draw conclusions. Polyprolpylene mesh tends to
provide superior outcomes compared with other surgical
repairs. For posterior vaginal wall prolapse surgery the
current evidence suggests there is no difference in
anatomic and quality-of-life outcomes when using
synthetic absorbable mesh, synthetic non-absorbable
mesh, or biologic graft compared with native tissue for
transvaginal repair of posterior vaginal prolapse. Due to
close proximity of pelvic viscera like bladder and rectum it
is recommended that selection of patients, procedure and
type of mesh should always be performed by experienced
surgeons. Surgical practices should not be
pharmaceutical driven and choice of mesh and the
procedure should be evidence based.
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